KRT19 and pancreatic neoplasm: Therefore, we first characterized the level of tumor burden in each murine model by staining murine pancreatic tumor sections for the expression of CK19, a marker of ductal cells, which is used as a marker for adenocarcinoma in the pancreas, with the level of staining indicative of tumor burden32 (Fig. 3A).